WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles:
Related suggestion:
Chinese tourist tower overlooking North Korea could be demolished — Radio Free AsiaScientists say oneSome imported animal products using production methods illegal in New ZealandRobert Kennedy Jr apologises to family over Super Bowl adTreaty referendum among issues raised with government at WaitangiSwedish alarm after defence chiefs' war warningChilean vet helps dogs, cats and rabbits injured in wildfiresTaiwan's remaining Pacific allies pledge supportLive updates: Hurricanes v Chiefs, Super Rugby Pacific round 8Motorcyclist seriously injured after crash in Auckland
1.8801s , 6496.3515625 kb
Copyright © 2024 Powered by New strategy to attack aggressive brain cancer shows promise ,Cosmic Compass news portal